Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.52, $0.01 better than the analyst estimate of $0.51. Revenue for the quarter came in at $800.7 million versus the consensus estimate of $799.44 million.

GUIDANCE:

Bruker sees FY2024 EPS of $2.59-$2.64, versus the consensus of $2.64. Bruker sees FY2024 revenue of $3.38-3.44 billion, versus the consensus of $3.4 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.